IL10 and neoplasm: The risk of tumorigenesis, the threshold concentration of TAA needed for stimulation, and the presence of immunosuppressive cytokines such as IL-10 and TGF-β that can offset proper anti-tumor response preclude the wide use of tumor lysates for vaccination [50].